首页> 外文期刊>Peptides: An International Journal >Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface.
【24h】

Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface.

机译:源自甲虫防御素的对映体9-mer肽对癌细胞的选择性细胞毒性取决于细胞表面带负电的磷脂酰丝氨酸。

获取原文
获取原文并翻译 | 示例
       

摘要

Four enantiomeric 9-mer peptides named d-peptide A, B, C and D were designed and synthesized on the basis of 43-mer insect defensins from two beetles. The d-9-mer peptides maintained bacterial membrane disruptive activity similar to the original peptides and also showed various extents of growth inhibitory activity against different cancer cell lines. Of these peptides, d-peptide B exhibited the highest selective cancer cell cytotoxicity against the mouse myeloma cell line, P3-X63-Ag8.653. Flow cytometric and scanning electron microscopic analysis revealed d-peptide B disrupts mouse myeloma membrane construction, whereas no cytotoxic effect on normal leukocytes was observed. Moreover, a strong correlation between negatively charged phosphatidylserine (PS) density in cancer cell membrane surface and sensitivity to d-9-mer peptides were observed in various cancer cell lines. These results suggest that d-9-mer peptides have negative charge-dependent selective cancer cell cytotoxicity targeting PS in the cancer cell membrane. In addition, synergic growth inhibitory activity against mouse myeloma was observed in combinations of d-peptide B and dexamethasone. These results suggest d-9-mer peptides are promising candidates for novel anticancer drugs.
机译:在来自两个甲虫的43-mer昆虫防御素的基础上,设计并合成了四种名为d-肽A,B,C和D的对映体9-mer肽。 d-9-mer肽保持与原始肽相似的细菌膜破坏活性,并且还显示出针对不同癌细胞系的不同程度的生长抑制活性。在这些肽中,d肽B对小鼠骨髓瘤细胞系P3-X63-Ag8.653表现出最高的选择性癌细胞毒性。流式细胞仪和扫描电子显微镜分析显示,d肽B破坏了小鼠骨髓瘤的膜结构,而未观察到对正常白细胞的细胞毒性作用。此外,在各种癌细胞系中,观察到癌细胞膜表面带负电荷的磷脂酰丝氨酸(PS)密度与对d-9-mer肽的敏感性之间存在很强的相关性。这些结果表明,d-9-mer肽具有靶向癌细胞膜中PS的负电荷依赖性选择性癌细胞毒性。另外,在d-肽B和地塞米松的组合中观察到了对小鼠骨髓瘤的协同生长抑制活性。这些结果表明,d-9-mer肽是新型抗癌药物的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号